pVSV eGFP dG Citations (24)
Originally described in: Anterograde or retrograde transsynaptic labeling of CNS neurons with vesicular stomatitis virus vectors.Beier KT, Saunders A, Oldenburg IA, Miyamichi K, Akhtar N, Luo L, Whelan SP, Sabatini B, Cepko CL Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15414-9. Epub 2011 Aug 8. PubMed Journal
Articles Citing pVSV eGFP dG
| Articles |
|---|
Anterograde or retrograde transsynaptic labeling of CNS neurons with vesicular stomatitis virus vectors.
Beier KT, Saunders A, Oldenburg IA, Miyamichi K, Akhtar N, Luo L, Whelan SP, Sabatini B, Cepko CL.
Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15414-9. Epub 2011 Aug 8.
PubMed
Associated Plasmids |
| Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library. Wang P, Liu Y, Zhang G, Wang S, Guo J, Cao J, Jia X, Zhang L, Xiao G, Wang W. J Virol. 2018 Jul 31;92(16). pii: JVI.00954-18. doi: 10.1128/JVI.00954-18. Print 2018 Aug 15. PubMed |
| Reversible Gene Regulation in Mammalian Cells Using Riboswitch-Engineered Vesicular Stomatitis Virus Vector. Takahashi K, Yokobayashi Y. ACS Synth Biol. 2019 Sep 20;8(9):1976-1982. doi: 10.1021/acssynbio.9b00177. Epub 2019 Aug 15. PubMed |
| Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells. Xiong HL, Wu YT, Cao JL, Yang R, Liu YX, Ma J, Qiao XY, Yao XY, Zhang BH, Zhang YL, Hou WH, Shi Y, Xu JJ, Zhang L, Wang SJ, Fu BR, Yang T, Ge SX, Zhang J, Yuan Q, Huang BY, Li ZY, Zhang TY, Xia NS. Emerg Microbes Infect. 2020 Dec;9(1):2105-2113. doi: 10.1080/22221751.2020.1815589. PubMed |
| Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol. Wang S, Li W, Hui H, Tiwari SK, Zhang Q, Croker BA, Rawlings S, Smith D, Carlin AF, Rana TM. EMBO J. 2020 Nov 2;39(21):e106057. doi: 10.15252/embj.2020106057. Epub 2020 Oct 5. PubMed |
| Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses. Wang R, Simoneau CR, Kulsuptrakul J, Bouhaddou M, Travisano KA, Hayashi JM, Carlson-Stevermer J, Zengel JR, Richards CM, Fozouni P, Oki J, Rodriguez L, Joehnk B, Walcott K, Holden K, Sil A, Carette JE, Krogan NJ, Ott M, Puschnik AS. Cell. 2021 Jan 7;184(1):106-119.e14. doi: 10.1016/j.cell.2020.12.004. Epub 2020 Dec 9. PubMed |
| Susceptibility of rabbits to SARS-CoV-2. Mykytyn AZ, Lamers MM, Okba NMA, Breugem TI, Schipper D, van den Doel PB, van Run P, van Amerongen G, de Waal L, Koopmans MPG, Stittelaar KJ, van den Brand JMA, Haagmans BL. Emerg Microbes Infect. 2021 Dec;10(1):1-7. doi: 10.1080/22221751.2020.1868951. PubMed |
| A protocol for displaying viral envelope glycoproteins on the surface of vesicular stomatitis viruses. Farzani TA, Chov A, Herschhorn A. STAR Protoc. 2020 Dec 9;1(3):100209. doi: 10.1016/j.xpro.2020.100209. eCollection 2020 Dec 18. PubMed |
| SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site. Mykytyn AZ, Breugem TI, Riesebosch S, Schipper D, van den Doel PB, Rottier RJ, Lamers MM, Haagmans BL. Elife. 2021 Jan 4;10. pii: 64508. doi: 10.7554/eLife.64508. PubMed |
| Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape. Koenig PA, Das H, Liu H, Kummerer BM, Gohr FN, Jenster LM, Schiffelers LDJ, Tesfamariam YM, Uchima M, Wuerth JD, Gatterdam K, Ruetalo N, Christensen MH, Fandrey CI, Normann S, Todtmann JMP, Pritzl S, Hanke L, Boos J, Yuan M, Zhu X, Schmid-Burgk JL, Kato H, Schindler M, Wilson IA, Geyer M, Ludwig KU, Hallberg BM, Wu NC, Schmidt FI. Science. 2021 Feb 12;371(6530). pii: science.abe6230. doi: 10.1126/science.abe6230. Epub 2021 Jan 12. PubMed |
| Screening of Botanical Drugs against Lassa Virus Entry. Liu Y, Guo J, Cao J, Zhang G, Jia X, Wang P, Xiao G, Wang W. J Virol. 2021 Feb 3. pii: JVI.02429-20. doi: 10.1128/JVI.02429-20. PubMed |
| SARS-CoV-2 ORF6 Disrupts Bidirectional Nucleocytoplasmic Transport through Interactions with Rae1 and Nup98. Addetia A, Lieberman NAP, Phung Q, Hsiang TY, Xie H, Roychoudhury P, Shrestha L, Loprieno MA, Huang ML, Gale M Jr, Jerome KR, Greninger AL. mBio. 2021 Apr 13;12(2). pii: mBio.00065-21. doi: 10.1128/mBio.00065-21. PubMed |
| Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization. Hennrich AA, Sawatsky B, Santos-Mandujano R, Banda DH, Oberhuber M, Schopf A, Pfaffinger V, Wittwer K, Riedel C, Pfaller CK, Conzelmann KK. PLoS Pathog. 2021 Apr 21;17(4):e1009064. doi: 10.1371/journal.ppat.1009064. eCollection 2021 Apr. PubMed |
| Inhaled ACE2-engineered microfluidic microsphere for intratracheal neutralization of COVID-19 and calming of the cytokine storm. Wang Z, Xiang L, Lin F, Cai Z, Ruan H, Wang J, Liang J, Wang F, Lu M, Cui W. Matter. 2022 Jan 5;5(1):336-362. doi: 10.1016/j.matt.2021.09.022. Epub 2021 Oct 19. PubMed |
| Variations in cell-surface ACE2 levels alter direct binding of SARS-CoV-2 Spike protein and viral infectivity: Implications for measuring Spike protein interactions with animal ACE2 orthologs. Kazemi S, Lopez-Munoz AD, Holly J, Jin L, Yewdell JW, Dolan BP. bioRxiv. 2021 Oct 22. doi: 10.1101/2021.10.21.465386. PubMed |
| Screening and Identification of Lujo Virus Entry Inhibitors From an Food and Drug Administration-Approved Drugs Library. Cao J, Dong S, Liu Y, Zhou M, Guo J, Jia X, Zhang Y, Hou Y, Tian M, Xiao G, Wang W. Front Microbiol. 2021 Dec 2;12:793519. doi: 10.3389/fmicb.2021.793519. eCollection 2021. PubMed |
| Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection. Biering SB, Sarnik SA, Wang E, Zengel JR, Leist SR, Schafer A, Sathyan V, Hawkins P, Okuda K, Tau C, Jangid AR, Duffy CV, Wei J, Gilmore RC, Alfajaro MM, Strine MS, Nguyenla X, Van Dis E, Catamura C, Yamashiro LH, Belk JA, Begeman A, Stark JC, Shon DJ, Fox DM, Ezzatpour S, Huang E, Olegario N, Rustagi A, Volmer AS, Livraghi-Butrico A, Wehri E, Behringer RR, Cheon DJ, Schaletzky J, Aguilar HC, Puschnik AS, Button B, Pinsky BA, Blish CA, Baric RS, O'Neal WK, Bertozzi CR, Wilen CB, Boucher RC, Carette JE, Stanley SA, Harris E, Konermann S, Hsu PD. Nat Genet. 2022 Aug;54(8):1078-1089. doi: 10.1038/s41588-022-01131-x. Epub 2022 Jul 25. PubMed |
| The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2. Xiong H, Sun H, Wang S, Yuan L, Liu L, Zhu Y, Zhang J, Huang Y, Qi R, Jiang Y, Ma J, Zhou M, Ma Y, Fu R, Yan S, Yue M, Wu Y, Wei M, Wang Y, Li T, Wang Y, Zheng Z, Yu H, Cheng T, Li S, Yuan Q, Zhang J, Guan Y, Zheng Q, Zhang T, Xia N. Proc Natl Acad Sci U S A. 2022 Aug 23;119(34):e2204256119. doi: 10.1073/pnas.2204256119. Epub 2022 Aug 16. PubMed |
| Variations in Cell Surface ACE2 Levels Alter Direct Binding of SARS-CoV-2 Spike Protein and Viral Infectivity: Implications for Measuring Spike Protein Interactions with Animal ACE2 Orthologs. Kazemi S, Lopez-Munoz AD, Holly J, Jin L, Yewdell JW, Dolan BP. J Virol. 2022 Sep 14;96(17):e0025622. doi: 10.1128/jvi.00256-22. Epub 2022 Aug 24. PubMed |
| Potential of conserved antigenic sites in development of universal SARS-like coronavirus vaccines. Wang S, Wu D, Xiong H, Wang J, Tang Z, Chen Z, Wang Y, Zhang Y, Ying D, Lin X, Liu C, Guo S, Tian W, Lin Y, Zhang X, Yuan Q, Yu H, Zhang T, Zheng Z, Xia N. Front Immunol. 2022 Sep 20;13:952650. doi: 10.3389/fimmu.2022.952650. eCollection 2022. PubMed |
| Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylation. Deng T, Li T, Chen G, Zhu Y, Xu L, Lin Y, Sun H, Zhang H, Fang Q, Hong J, Wu D, Gao S, Li S, Wang Y, Zhang T, Chen Y, Yuan Q, Zheng Q, Yu H, Zhao Q, Zhang J, Li S, Xia N, Gu Y. Vaccine. 2022 Nov 8;40(47):6839-6848. doi: 10.1016/j.vaccine.2022.09.057. Epub 2022 Sep 26. PubMed |
| Screening and Identification of Lassa Virus Entry Inhibitors from a Fragment-Based Drug Discovery Library. Hou Y, Liu Y, Jia X, Zhou M, Mao W, Dong S, Zhang Y, Xiao G, Wang W. Viruses. 2022 Nov 27;14(12):2649. doi: 10.3390/v14122649. PubMed |
| Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammals. Li M, Du J, Liu W, Li Z, Lv F, Hu C, Dai Y, Zhang X, Zhang Z, Liu G, Pan Q, Yu Y, Wang X, Zhu P, Tan X, Garber PA, Zhou X. ISME J. 2023 Apr;17(4):549-560. doi: 10.1038/s41396-023-01368-2. Epub 2023 Jan 23. PubMed |
| Integrative analysis of functional genomic screening and clinical data identifies a protective role for spironolactone in severe COVID-19. Cousins HC, Kline AS, Wang C, Qu Y, Zengel J, Carette J, Wang M, Altman RB, Luo Y, Cong L. Cell Rep Methods. 2023 May 29;3(7):100503. doi: 10.1016/j.crmeth.2023.100503. eCollection 2023 Jul 24. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.